eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
 
3/2021
vol. 37
 
Share:
Share:
more
 
 
abstract:
Review paper

Sublingual and subcutaneous allergen-specific immunotherapy as a method of treatment of patients with inhalant allergy – a review of the literature

Angelika Pawlak
1
,
Gabriela Ręka
1
,
Anna Korzeniowska
1
,
Halina Piecewicz-Szczęsna
1

1.
Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Lublin, Poland
Medical Studies/Studia Medyczne 2021; 37 (3): 250–257
Online publish date: 2021/09/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Allergy is the result of the body’s intolerance to harmless antigens. In the treatment of respiratory allergies, allergen immunotherapy (AIT) is a causal method of treating allergies. It can be carried out via the subcutaneous route (SCIT) or the sublingual route (SLIT) – in the form of drops or tablets. Desensitisation is recommended from the age of 5 years, and the doses of the drug should be repeated gradually so that the body acquires immunological tolerance to allergens. Thirty-six current publications from the PubMed and Google Scholar platforms were reviewed. A series of studies confirming the safety, efficacy, and good tolerability of both types of AIT in children and adults were referred to. The results presented in the review show the similarities and differences between the desensitisation methods. They differ, among other things, in the convenience of use, the price, the frequency of side effects of treatment, and the dosage.
keywords:

allergy, allergic rhinitis, desensitisation, allergen immunotherapy

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.